B. Breit et al.
tography on silica gel (CH2Cl2/EE, 20:1) to afford the monopeptidyl
phosphane 8e as a glass foam (0.913 g, 89%, Rf =0.62). M.p. 938C
(CH2Cl2/EE); [a]2D0 =ꢀ14.18 (c=0.655 in CHCl3); 1H NMR (400 MHz,
CDCl3): d=1.45 (d, J=5.4 Hz, 3H; 3-H3), 4.19 (t, J=6.6 Hz, 1H; 6-H),
4.42 (m, J=6.7 Hz, 3H; 2-H, 5-H2), 5.39 (brs, 1H; 2-NH), 6.80 (d, J=
7.5 Hz, 1H; 5’-H), 7.25–7.43 (m, 14H; ArH), 7.52–7.64 (m, J=8.1 Hz,
3H; 4’-H, fluorenyl H), 7.75 (d, J=7.5 Hz, 2H; fluorenyl H), 8.10 (d, J=
8.4 Hz, 1H; 3’-H), 8.44 ppm (brs, 1H; 2’-NH); 13C NMR (100 MHz,
CDCl3): d=18.8 (C3), 47.2 (C6), 51.6 (C2), 67.3 (C5), 113.0 (C3’), 120.1
(2 fluorenyl C), 124.5 (d, JC,P =12.1 Hz; C5’), 125.1 (2 fluorenyl C), 127.2
(2 fluorenyl C), 127.8 (2 fluorenyl C), 128.7 (d, JC,P =7.2 Hz; 4ArCmeta),
2008C/0.5 mbar; 1H NMR (400 MHz, CDCl3): d=0.00 (s, 18H; SiMe3),
6.77 (ddd, J=7.8, 1.7, 1.7 Hz, 1H; 6-H), 6.88 (d, J=7.8 Hz, 1H; 2-H),
7.04 (dd, J=7.8, 7.8 Hz, 1H; 4-H), 7.20 (ddd, J=7.8, 7.8, 2.0 Hz, 1H; 5-
H), 7.28–7.40 ppm (m, 10H; PPh2); 31P NMR (121 MHz, CDCl3): d=
ꢀ5.70 ppm (s). The TMS-protected aniline (10.24 g, 24.29 mmol) was hy-
drolyzed with aqueous HCl (2n, 50 mL) in MeOH (150 mL) and stirred
for 2 h at room temperature. The reaction mixture was then neutralised
with aqueous NaOH (2n, 50 mL) and extracted with Et2O (3ꢄ150 mL).
The combined organic layers were dried (MgSO4) and concentrated in
vacuo. The residue was recrystallised from CH2Cl2 to afford the phos-
phane-substituted aniline 10 as a white to pale yellow solid (6.75 g,
quant.). M.p. 878C (PE/EE); 1H NMR (400 MHz, CDCl3): d=3.60 (brs,
2H; NH2), 6.59–6.77 (m, J=7.8 Hz, 3H; 2-H, 4-H, 6-H), 7.14 (ddd, J=
7.8, 7.8, 1.8 Hz, 1H; 5-H), 7.28–7.42 ppm (m, 10H; ArH); 13C NMR
(100 MHz, CDCl3): d=115.6 (C6), 120.1 (d, JC,P =20.2 Hz; C2), 124.1 (d,
129.3 (2ArCpara), 134.2 (d, JC,P =19.9 Hz; 4ArCortho), 135.8 (2d, JC,P
=
10.5 Hz; 2ArCipso), 138.2 (d, JC,P =1.4 Hz; C4’), 141.4 (2 fluorenyl C), 143.8
(fluorenyl C), 143.9 (fluorenyl C), 151.1 (d, JC,P =14.1 Hz; C6’), 156.0 (C4),
162.3 (d, JC,P =3.7 Hz; C2’), 171.1 ppm (C1); 31P NMR (121 MHz, CDCl3):
d=ꢀ4.04 ppm (s); elemental analysis calcd (%) for C35H30N3O3P: C
73.54, H 5.29, N 7.35; found: C 73.35, H 5.39, N 7.30.
J
C,P =19.9 Hz; C4), 128.5 (d, JC,P =6.9 Hz; 4ArCmeta), 128.7 (2ArCpara),
129.4 (d, JC,P =8.1 Hz; C5), 133.8 (d, JC,P =19.6 Hz; 4ArCortho), 137.4 (d,
J
C,P =10.9 Hz; 2ArCipso), 138.2 (d, JC,P =10.1 Hz; C3), 146.5 ppm (d, JC,P =
(ꢀ)-(6-Diphenylphosphanyl)-2-aminopyridinyl-l-alanyl-l-valine-Boc (8 f):
Et2NH (0.70 mL, 6.7 mmol, 19 equiv) was added to a solution of the
Fmoc-protected peptidyl ligand 8e (0.200 g, 0.350 mmol) in dry THF
(2 mL) and stirred at room temperature for 3.5 h (TLC control: PE/EE,
2:1). Evaporation in vacuo gave a waxy oil (quant.). The free amine was
dissolved in dry CH2Cl2 (3 mL) and treated successively with Boc-l-
valine (76 mg, 0.35 mmol, 1.0 equiv), HOBt (47 mg, 0.35 mmol, 1.0 equiv)
and DIC (44 mg, 0.35 mmol, 1.0 equiv) at room temperature. The result-
ing solution was stirred at room temperature for a further 20 h and con-
centrated in vacuo. The residue was subjected to chromatography on
silica gel (CH2Cl2/EE, 10:1) to afford the dipeptidyl ligand 8 f as a glass
8.1 Hz; C1); 31P NMR (121 MHz, CDCl3): d=ꢀ4.53 ppm (s); HRMS
(EIMS): m/z: calcd for C18H16NP: 277.1020 [M+]; found: 277.1017; ele-
mental analysis calcd (%) for C18H16NP: C 77.96, H 5.82, N 5.05; found:
C 77.87, H 5.94, N 4.80.
N-(3-Diphenylphosphanyl-phenyl)-2-phenylacetamide (11a): Phenylacetyl
chloride (0.239 g, 1.54 mmol, 1.07 equiv) was added to a solution of 3-
DPPA (10) (0.400 g, 1.44 mmol) and pyridine (0.186 g, 2.35 mmol,
1.6 equiv) in dry CH2Cl2 (6 mL) at 08C. The cooling bath was removed
and the reaction mixture was stirred 18 h at room temperature. The re-
sulting clear solution was washed with half-saturated aqueous KHSO4
(4 mL) and saturated aqueous NaHCO3 (4 mL) and dried (Na2SO4).
Evaporation in vacuo afforded the amide 11a as a pale yellow foam
foam (0.115 g, 60%, Rf =0.47 with 5:1). M.p. 958C (CH2Cl2/EE); [a]D20
=
1
ꢀ31.08 (c=1.200 in CHCl3); H NMR (400 MHz, CDCl3): d=0.87 (d, J=
6.7 Hz, 3H; 7-H3 or 8-H3), 0.90 (d, J=7.0 Hz, 3H; 7-H3 or 8-H3), 1.42 (s,
9H; tBu), 1.43 (overlapped d, J=7.2 Hz, 3H; 3-H3), 2.08 (mc, J=6.5 Hz,
1H; 6-H), 3.94 (dd, J=7.2, 7.0 Hz, 1H; 5-H), 4.66 (dq, J=7.2, 7.0 Hz,
1H; 2-H), 5.13 (brs, 1H; 5-NH), 6.67 (d, J=7.0 Hz, 1H; 2-NH), 6.78 (d,
J=7.5 Hz, 1H; 5’-H), 7.29–7.38 (m, 10H; PPh2), 7.56 (dd, J=8.1, 7.8 Hz,
1H; 4’-H), 8.06 (d, J=8.4 Hz, 1H; 3’-H), 8.57 ppm (brs, 1H; 2’-NH);
13C NMR (100 MHz, CDCl3): d=17.9, 19.4 (C7, C8), 18.4 (C3), 28.4
(3C11), 31.0 (C6), 49.8 (C2), 60.0 (C5), 80.0 (C10), 112.9 (C3’), 124.4 (d,
1
(0.566 g, 99%, Rf =0.50 with PE/EE, 2:1). M.p. 408C (CH2Cl2); H NMR
(400 MHz, CDCl3): d=3.68 (s, 2H; 2-H2), 6.98 (dd, J=7.3, 7.0 Hz, 1H;
5’-H), 7.10 (s, 1H; NH), 7.15 (d, J=8.5 Hz, 1H; ArH), 7.20–7.43 (m,
16H; ArH), 7.67 ppm (d, J=7.9 Hz, 1H; ArH); 13C NMR (100 MHz,
CDCl3): d=44.8 (C2), 120.8 (C6’), 125.2 (d, JC,P =24.8 Hz; C2’), 127.7 (C6),
128.6 (d, JC,P =6.4 Hz; 4ArCmeta), 128.9 (2ArCpara), 129.29 (overlapped d,
J
C,P =6.4 Hz; C5’), 129.30 (2C5), 129.6 (2C4), 129.6 (d, JC,P =14.7 Hz; C4’),
133.8 (d, JC,P =19.3 Hz; 4ArCortho), 134.4 (C3), 136.8 (d, JC,P =11.0 Hz;
J
C,P =13.3 Hz; C5’), 128.7 (d, JC,P =7.2 Hz; 4ArCmeta), 129.2 (2ArCpara),
2ArCipso), 137.9 (d, JC,P =9.2 Hz; C1’), 138.3 (d, JC,P =12.0 Hz; C3’),
134.2 (2d, JC,P =19.8 Hz; 4ArCortho), 135.9 (2d, JC,P =10.4 Hz; 2ArCipso),
138.1 (C4’), 151.1 (d, JC,P =13.8 Hz; C6’), 156.0 (C9), 162.2 (d, JC,P =3.6 Hz;
C2’), 170.9, 171.8 ppm (C1, C4); 31P NMR (121 MHz, CDCl3): d=
ꢀ4.09 ppm (s); HRMS (EIMS): m/z: calcd for C30H37N4O4P: 548.2552
[M+]; found: 548.2562.
169.1 ppm (C1); 31P NMR (121 MHz, CDCl3): d=ꢀ4.85 ppm (s); HRMS
(EIMS): m/z: calcd for C26H22NOP: 395.1439 [M+]; found: 395.1439; ele-
mental analysis calcd (%) for C26H22NOP: C 78.97, H 5.61, N 3.54;
found: C 78.68, H 5.68, N 3.28.
(ꢀ)-Fmoc-l-valyl-(3-diphenylphosphanyl)anilide (11b): SOCl2 (2.0 mL,
27 mmol, 9 equiv) was added to a suspension of Fmoc-l-valine (1.00 g,
2.94 mmol) in dry CH2Cl2 (5 mL) and stirred 1 h at 50–558C. The clear
reaction mixture was concentrated in vacuo and the residue was re-dis-
solved in dry CH2Cl2 (3 mL). The solvent was removed in vacuo and this
procedure was repeated two more times to give Fmoc-l-Val-Cl as a mois-
ture-sensitive white solid (1.06 g, 2.94 mmol, quant.). The amino acid
chloride was dissolved in dry CH2Cl2 (4 mL) and was added dropwise at
08C to a solution of 3-DPPA (10) (0.753 g, 2.71 mmol, 0.92 equiv) and
pyridine (0.25 mL, 3.04 mmol, 1.03 equiv) in dry CH2Cl2 (8 mL). The
yellow solution was stirred at room temperature for a further 5 h, then
washed with half-saturated aqueous KHSO4 (10 mL) and saturated aque-
ous NaHCO3 (10 mL), and dried (MgSO4). The organic layer was con-
centrated in vacuo and the crude product was purified twice by column
chromatography on silica gel (PE/EE, 4:1) to afford the monopeptidyl
phosphane 11b as a glass foam (1.389 g, 84%, Rf =0.45 with 2:1). M.p.
878C (CH2Cl2); [a]2D0 =ꢀ21.08 (c=0.795 in CHCl3); 1H NMR (400 MHz,
CDCl3): d=0.97 (brs, 6H; 4-H3, 5-H3), 2.17 (mc, 1H; 3-H), 4.09 (mc, 1H;
2-H), 4.17 (t, J=6.7 Hz, 8-H), 4.28–4.48 (m, J=7.2 Hz, 2H; 7-H2), 5.54
(brs, 1H; 2-NH), 7.01 (dd, J=7.2, 7.2 Hz, 1H; ArH), 7.18–7.42 (m, J=
7.5 Hz, 16H; ArH), 7.43 (d, J=7.5 Hz, 2H; ArH), 7.70 (d, J=8.2 Hz,
1H; ArH), 7.75 (d, J=7.5 Hz, 2H; ArH), 8.07 ppm (brs, 1H; 1’-NH);
13C NMR (100 MHz, CDCl3): d=18.1, 19.4 (C4, C5), 31.1 (C3), 47.2 (C8),
61.4 (C2), 67.3 (C7), 120.1 (2 fluorenyl C), 120.8 (C6’), 125.1 (2 fluorenyl
C), 125.2 (overlapped d, JC,P =22.5 Hz; C2’), 127.2 (2 fluorenyl C), 127.8
(2 fluorenyl C), 128.6 (d, JC,P =6.9 Hz; 4ArCmeta), 128.9 (2ArCpara), 129.3
3-Diphenylphosphanylaniline (3-DPPA) (10): nBuLi (164 mL, 216 mmol,
2.3 equiv, 1.32m in hexanes) was added dropwise to a solution of 3-bro-
moaniline (9) (10.1 mL, 16.0 g, 93.0 mmol) in dry THF (100 mL) at 08C
and stirred for a further 3 h at room temperature. After dropwise addi-
tion of chlorotrimethylsilane (27.5 mL, 23.4 g, 215.2 mmol, 2.15 equiv) at
08C, the resulting turbid brown reaction mixture was stirred at room
temperature for a further 17 h. The precipitated LiCl was rapidly re-
moved by filtration through a short pad of Celite and washed with dry
Et2O (100 mL). The solution was concentrated in vacuo and the black
residue was distilled using a Vigreux column to give 3-bromo-N,N-bis(tri-
methylsilyl)aniline as a yellow liquid (14.22 g, 48%). B.p. 888C/0.5 mbar;
1H NMR (300 MHz, CDCl3): d=0.07 (s, 18H; SiMe3), 6.81 (mc, J=
7.9 Hz, 1H; 6-H), 7.04–7.10 (m, J=7.9, 7.9 Hz, 2H; ArH), 7.12 ppm (mc,
J=7.9 Hz, 1H; ArH); 13C NMR (75 MHz, CDCl3): d=2.1 (SiMe3), 121.9
(C3), 126.8, 128.9, 129.7, 133.1 (C2, C4, C5, C6), 150.0 ppm (C1). nBuLi
(21.8 mL, 34.8 mmol, 1.1 equiv, 1.60m in hexanes) was added dropwise to
a solution of 3-bromo-N,N-bis(trimethylsilyl)aniline (10.30 g, 32.55 mmol)
in dry Et2O (30 mL) at 08C. After stirring for 3 h at 08C, freshly distilled
chlorodiphenylphosphine (7.68 g, 34.8 mmol, 1.1 equiv) was added drop-
wise at 08C and the turbid beige reaction mixture was stirred at room
temperature for a further 18 h. The precipitated LiBr was removed by fil-
tration through a short pad of Celite and washed with Et2O. The solution
was concentrated in vacuo, and Kugelrohr distillation of the red-brown
residue afforded 3-[N,N-bis(trimethylsilyl)aminophenyl]diphenylphos-
phine as a pale yellow oil (12.02 g, 88%, Rf =0.45 with PE/EE, 2:1). B.p.
10418
ꢂ 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2009, 15, 10405 – 10422